Author: Ken Dropiewski

BioSig Technologies, Inc. Appoints John Sieckhaus as Chief Operating Officer

Seasoned electrophysiology commercial leader joins the Company to expand operating capabilities Westport, CT, March 16, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG […]

Avive Secures $22 Million in Series A Funding to Advance Intelligent AED and Lifesaving Platform for Out-of-Hospital Cardiac Arrest

Deployment of a Novel 4-Minute City Program that Engages Community Members to Speed AED Response Time, Improve Survival Rates and Focus on Overcoming Socioeconomic Disparities in Healthcare SAN FRANCISCO, March 16, 2022 /PRNewswire/ — Avive Solutions, Inc., developer of an intelligent AED and connected response platform for out-of-hospital cardiac arrest (OHCA) emergencies, today […]

Lark Health Builds AI-Driven Heart Health Program

New Program Will Provide Real-Time Coaching to Support the Prevention and Management of Atherosclerotic Cardiovascular Disease and Coronary Artery Disease  MOUNTAIN VIEW, Calif., March 16, 2022 /PRNewswire/ — Lark Health today announced the development of a novel AI-driven program for the prevention and management of atherosclerotic cardiovascular disease (ASCVD) and coronary artery disease (CAD) […]

Circle Cardiovascular Imaging Announces Strategic Growth Investment from Thoma Bravo

Investment to drive future growth and innovation and strengthen market leadership position CALGARY, AB and SAN FRANCISCO, March 16, 2022 /PRNewswire/ — Circle Cardiovascular Imaging Inc. (“Circle CVI”), the global leader in cardiovascular imaging solutions, today announced a strategic growth investment from Thoma Bravo, a leading software investment firm. Thoma Bravo’s partnership is expected […]

CareDx Brings Together Leading Transplant Experts to Share Latest Advancements in the Field of Xenotransplantation

SOUTH SAN FRANCISCO, Calif., March 16, 2022 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it will hold a virtual “Xenotransplantation Innovation Day” featuring a […]

Vivasure Medical Announces First Patient Treated in U.S. Early Feasibility Study Evaluating PerQseal+

Study is the first in the U.S. to evaluate the company’s fully absorbable, patch-based percutaneous closure device for large-bore vessels in transcatheter aortic valve replacement GALWAY, Ireland–(BUSINESS WIRE)–Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that the first patient was treated in a […]

Cardiawave Announces the Success of Its Clinical Trial to Treat Aortic Stenosis Using VALVOSOFT®, Its Disruptive, Non-Invasive, Ultrasound Treatment

The trial with VALVOSOFT® its disruptive, non-invasive, ultrasound treatment was proven to: be safe and feasible provide a sustained repair of the aortic valve improve quality of life of the 34 patients treated PARIS–(BUSINESS WIRE)–Cardiawave SA, a deeptech medical device company that has developed VALVOSOFT® a revolutionary non-invasive medical device to […]